Biomarker-Guided Steroid Therapy Shown Safe for COPD Biomarker-Guided Steroid Therapy Shown Safe for COPD
Treatment failure rates not significantly lower for eosinophil-guided prescribing of corticosteroids compared with empiric prescribing.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 7, 2022 Category: Consumer Health News Tags: Pulmonary Medicine News Source Type: news
Are Antibiotics Needed for Moderate Acute Exacerbations of COPD?
(MedPage Today) -- BARCELONA -- The need for antibiotics in patients with chronic obstructive pulmonary disease (COPD) seeking treatment for moderate acute COPD exacerbations could not be ruled out in a randomized trial from Germany, except perhaps... (Source: MedPage Today Allergy)
Source: MedPage Today Allergy - September 7, 2022 Category: Allergy & Immunology Source Type: news
Bronchodilator Does Not Improve Respiratory Symptoms for Tobacco - Exposed
No reduction seen in respiratory symptoms for symptomatic, tobacco - exposed persons without formal diagnosis of COPD (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - September 6, 2022 Category: Respiratory Medicine Tags: Internal Medicine, Pharmacy, Pulmonology, Conference News, Source Type: news
RETHINC Takes Air Out of COPD-like Therapy for Smokers RETHINC Takes Air Out of COPD-like Therapy for Smokers
Dual-acting bronchodilators were no better than placebo for symptoms in smokers without airway obstruction.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 6, 2022 Category: Consumer Health News Tags: Pulmonary Medicine News Source Type: news
Bronchodilators don ’t improve smoking-related respiratory symptoms in people without COPD
About 20 –40% of adults with COPD symptoms but who aren’t diagnosed with COPD use these types of long-lasting inhalers . (Source: National Institutes of Health (NIH) News Releases)
Source: National Institutes of Health (NIH) News Releases - September 4, 2022 Category: American Health Source Type: news
Air Pollution Kills Millions Every Year: Action Needed
The World Health Organization calls air pollution the “single biggest environmental threat to human health" and estimates that 99 percent of the world’s population live in locations that are above WHO thresholds designed to protect human health. . Credit: Malav Goswami/IPSBy Felix HorneSep 2 2022 (IPS) Tarik, age 42, lives in a village adjacent to a decades-old coal power plant in Bosnia and Herzegovina. On the day we visited, Bosnian cities were some of the most polluted places on Earth. Describing the devastating health toll the air pollution took each year on the village’s older residents he voiced his fear for hi...
Source: IPS Inter Press Service - Health - September 2, 2022 Category: International Medicine & Public Health Authors: Felix Horne Tags: Environment Global Headlines Health Source Type: news
Man, 75, has eye-lids swell so large that he could not open them
An unnamed man, 75, suffered face swelling so severe he could not open his eyes after he received surgery for his COPD. He suffered from subcutaneous emphysema. (Source: the Mail online | Health)
Source: the Mail online | Health - September 1, 2022 Category: Consumer Health News Source Type: news
4DMedical tests AI algorithm in U.S. veterans with lung disease
4DMedical's lung ventilation analysis algorithm has been tested successfull...Read more on AuntMinnie.comRelated Reading:
Calif. hospital touts first use of new lung imaging software
4DMedical, Johns Hopkins University partner on COPD trial
4DMedical reports NIH funding for preclinical scanner
Meet the Minnies 2020 semifinal candidates
4DMedical gets FDA clearance for lung analysis software (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - September 1, 2022 Category: Radiology Source Type: news
Sclerostin Predicts Exacerbations in COPD Patients Sclerostin Predicts Exacerbations in COPD Patients
Age and body composition were positively associated with serum sclerostin levels.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - August 29, 2022 Category: Consumer Health News Tags: Pulmonary Medicine News Source Type: news
Final Analysis of Phase 2 GRIFFIN Study Presented for DARZALEX ® (daratumumab)-based Investigational Quadruplet Regimen in Patients with Newly Diagnosed, Transplant-Eligible Multiple Myeloma
LOS ANGELES, August 27, 2022 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today the final results from the randomized Phase 2 GRIFFIN study evaluating the investigational use of DARZALEX® (daratumumab) in combination with lenalidomide (Revlimid®), bortezomib (VELCADE®) and dexamethasone (DARZALEX®-RVd), followed by maintenance therapy with DARZALEX®-lenalidomide (R), compared to RVd followed by maintenance therapy with R alone, in patients with newly diagnosed, transplant-eligible multiple myeloma. Data were presented in the plenary session at the 19th International Myeloma Society (IMS)...
Source: Johnson and Johnson - August 28, 2022 Category: Pharmaceuticals Source Type: news
Lupin's arm gets UK regulator nod for COPD treatment
Global pharma major Lupin Limited on Friday announced that its UK subsidiary, Lupin Healthcare (UK) Limited, has received approval from the Medicines and Healthcare products Regulatory Agency (MHRA) to market a generic version of Spiriva, stated a press release. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - August 26, 2022 Category: Pharmaceuticals Source Type: news
Screen COPD Patients for Peripheral Neuropathy Screen COPD Patients for Peripheral Neuropathy
Authors of a current review acknowledge treatment limitations but found a high prevalence of peripheral neuropathy among patients with COPD.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - August 22, 2022 Category: Consumer Health News Tags: Pulmonary Medicine News Source Type: news
Dark-field chest x-ray differentiates lung disease
Investigators from Germany say that their prototype dark-field chest x-ray syste...Read more on AuntMinnie.comRelated Reading:
Can dark-field chest x-ray diagnose COVID-19 pneumonia?
Dark-field CT moves closer to human medical applications
Chest x-ray prototype shows promise imaging lungs
Dark-field x-ray shows promise for diagnosing emphysema in COPD
New x-ray imaging technique emerges from the dark (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - August 22, 2022 Category: Radiology Source Type: news
Raleigh pharma raising $122M to prep for potential commercialization
A Raleigh company developing a COPD treatment is raising more than $100 million as it moves closer to seeking regulatory approval. (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - August 14, 2022 Category: American Health Authors: Zac Ezzone Source Type: news
The orange snack that could 'boost' lung health and 5 other tips to help your breathing
THERE are multiple different types of lung conditions and diseases that, especially in the intense heat, can make breathing difficult. Conditions such as chronic obstructive pulmonary disease , asthma and bronchitis, are all examples of conditions that can be negatively affected by heat. However, all is not lost, as below are some tips that can help individuals breathe easier across the unprecedented heatwave, some of which you may find surprising. (Source: Daily Express - Health)
Source: Daily Express - Health - August 14, 2022 Category: Consumer Health News Source Type: news
